Treatment of Myasthenia Gravis After Thymectomy

  • Pierre-Antoine Uldry
  • Franco Regli


The principal drugs used for the treatment of myasthenia gravis (MG) are presented in Chap. 12. We consider here the practical treatment of patients in the weeks and months following thymectomy.


Plasma Exchange Neurol Neurosurg Psychiatry Anticholinesterase Drug Thoracic Duct Drainage Concomitant Steroid Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aquilonius SM, Eckernäs SA, Hartvig P, Lindström B, Oster- man PO, Stalberg E (1983) Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 46: 929–935PubMedCrossRefGoogle Scholar
  2. Davison SC, Hyman NM, Dehghan A, Chan K (1981) The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 44: 1141–1145PubMedCrossRefGoogle Scholar
  3. Drachman DB (1987) Present and future treatment of myasthenia gravis. N Engl J Med 316: 743–745PubMedCrossRefGoogle Scholar
  4. Engel AG (1984) Myasthenia gravis and myasthenic syndromes. Ann Neurol 16: 519 - 534PubMedCrossRefGoogle Scholar
  5. Hohlfeld R, Michels M, Heininger K, Besinger U, Toyka KV (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38: 258–261PubMedGoogle Scholar
  6. Howard JF Jr (1982 a) Nonsteroidal immunosuppressive therapy for myasthenia gravis. Semin Neurol 2: 265–269Google Scholar
  7. Howard JF Jr (1982 b) Treatment of myasthenia gravis with plasma exchange. Semin Neurol 2: 273–279Google Scholar
  8. Johns TR (1987) Long-term corticosteroid treatment of myasthenia gravis. Ann NY Acad Sei 505: 568–583CrossRefGoogle Scholar
  9. Levine SE, Keesey JC (1986) Successful plasmapheresis for fulminant myasthenia gravis during pregnancy. Arch Neurol 43: 197–198PubMedGoogle Scholar
  10. Michels M, Hohlfeld R, Härtung HP, Heininger K, Besinger UA, Toyka KV (1988) Myasthenia gravis: discontinuation of long-term azathioprine. Ann Neurol 24: 798 (letter)Google Scholar
  11. Newsom-Davis J (1986) Diseases of the neuromuscular junction. In: Asbury AK, McKhann GM, McDonald WI (eds) Diseases of the nervous system, vol 1. Heinemann Medical, London, pp 269–282Google Scholar
  12. Newsom-Davis J, Wilson SG, Vincent A, Ward CD (1979) Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1: 464–468PubMedCrossRefGoogle Scholar
  13. Nielsen VK, Paulson OB, Rosenkvist J, Holsoe E, Lefvert AK (1982) Rapid improvement of myasthenia gravis after plasma exchange. Ann Neurol 11: 160–169PubMedCrossRefGoogle Scholar
  14. Nyberg-Hansen R, Gjerstad L (1988) Myasthenia gravis treated with cyclosporin. Acta Neurol Scand 77: 307–313PubMedCrossRefGoogle Scholar
  15. Oosterhuis HJ (1981) Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann NY Acad Sei 377: 678–690CrossRefGoogle Scholar
  16. Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fa- gerstrom RP, Pozner J, Aufses AH Jr (1987) Effects of thymectomy in myasthenia gravis. Ann Surg 206: 79–88PubMedCrossRefGoogle Scholar
  17. Pascuzzi RM, Coslett HB, Johns TR (1984) Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 15: 291–298PubMedCrossRefGoogle Scholar
  18. Rodnitzky RL, Bosch EP (1984) Chronic long-interval plasma exchange in myasthenia gravis. Arch Neurol 41: 715–717PubMedGoogle Scholar
  19. Rowland LP (1980) Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry 43: 644–659PubMedCrossRefGoogle Scholar
  20. Scadding GK, Havard CWH, Lange MJ, Domb I (1985) The long term experience of thymectomy for myasthenia gravis. J Neurol Neurosurg Psychiatry 48: 401–406PubMedCrossRefGoogle Scholar
  21. Schümm F, Wiethölter H, Fateh-Moghadam A, Dichgans J (1985) Thymectomy in myasthenia with pure ocular symptoms. J Neurol Neurosurg Psychiatry 48: 332–337PubMedCrossRefGoogle Scholar
  22. Sghirlanzoni A, Peluchetti D, Mantegazza R, Fiacchino F, Cornelio F (1984) Myasthenia gravis: prolonged treatment with steroids. Neurology 34: 170–174PubMedGoogle Scholar
  23. Tindall RSA, Rollins J A, Phillips JT, Greenlee RG, Wells L, Belendiuk G (1987) Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316: 719–724PubMedCrossRefGoogle Scholar
  24. White MC, De Silva P, Havard CWH (1981) Plasma pyridostigmine levels in myasthenia gravis. Neurology 31: 145–150PubMedGoogle Scholar
  25. Witte AS, Cornblath DR, Parry GJ, Lisak RP, Schatz WNJ (1984) Azathioprine in the treatment of myasthenia gravis. Ann Neurol 15: 602–605PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Pierre-Antoine Uldry
  • Franco Regli

There are no affiliations available

Personalised recommendations